Literature DB >> 21103466

Catalytic asymmetric synthesis of 1,1-disubstituted tetrahydro-β-carbolines by phase-transfer catalyzed alkylations.

Seiji Shirakawa1, Kun Liu, Hironobu Ito, Keiji Maruoka.   

Abstract

Efficient catalytic asymmetric synthesis of 1,1-disubstituted tetrahydro-β-carbolines has been achieved via asymmetric alkylation of 1-cyanotetrahydro-β-carbolines using a binaphthyl-modified N-spiro-type chiral phase-transfer catalyst. This is a valuable example of hitherto difficult highly enantioselective alkylations at α-carbon of the cyano group under phase-transfer conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21103466     DOI: 10.1039/c0cc04447d

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

1.  Design, synthesis, and application of tartaric acid derived N-spiro quaternary ammonium salts as chiral phase-transfer catalysts.

Authors:  Mario Waser; Katharina Gratzer; Richard Herchl; Norbert Müller
Journal:  Org Biomol Chem       Date:  2011-10-31       Impact factor: 3.876

2.  Investigations Concerning the Syntheses of TADDOL-Derived Secondary Amines and Their Use To Access Novel Chiral Organocatalysts.

Authors:  Katharina Gratzer; Mario Waser
Journal:  Synthesis (Stuttg)       Date:  2012-12       Impact factor: 3.157

3.  Asymmetric cyclopropanation of chalcones using chiral phase-transfer catalysts.

Authors:  Richard Herchl; Mario Waser
Journal:  Tetrahedron Lett       Date:  2013-05-15       Impact factor: 2.415

4.  Catalytic Enantioselective Pictet-Spengler Reaction of α-Ketoamides Catalyzed by a Single H-Bond Donor Organocatalyst.

Authors:  Rémi Andres; Qian Wang; Jieping Zhu
Journal:  Angew Chem Int Ed Engl       Date:  2022-03-11       Impact factor: 16.823

5.  Application scope and limitations of TADDOL-derived chiral ammonium salt phase-transfer catalysts.

Authors:  Guddeangadi N Gururaja; Richard Herchl; Antonia Pichler; Katharina Gratzer; Mario Waser
Journal:  Molecules       Date:  2013-04-12       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.